Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 432
Selected: 0
NCT IDTitle
NCT06566248A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
NCT04952493Anlotinib or Penpulimab in Combination With RAI for DTC
NCT02809534A Study of Anlotinib in Patients With Hepatocellular Carcinoma
NCT02944864A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics
NCT04619537A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer
NCT04412577A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies
NCT03778138Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC
NCT07367529A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
NCT05800418Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers
NCT05193604A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma
NCT05451407Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma
NCT03750916Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
NCT02072044Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy
NCT05496569TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
NCT06122831A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
NCT05033587Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
NCT05987371A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.
NCT03850873A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics
NCT03510767A Study of TQ-B3525 on Tolerance and Pharmacokinetics
NCT05481645Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
NCT05400876To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma
NCT07252908A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
NCT06700395A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT06854445Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
NCT04398953A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)
NCT02586337Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
NCT07407803Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas
NCT04073550Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer
NCT04355520A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
NCT04842526Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study
NCT05011019A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis
NCT04836663A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors
NCT05765357Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers
NCT01886053A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT06829771Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
NCT06860971A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06825494Clinical Studies for the Treatment of Advanced Solid Tumors
NCT05051930A Clinical Trial of TQC3721 Suspension for Inhalation
NCT06160895A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
NCT03754244A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics
NCT06448273A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects
NCT05834543Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT07483684A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
NCT06010901A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
NCT05306847Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer
NCT04398940A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer
NCT04805060A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors
NCT03771781Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.
NCT02825563A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients
NCT06218771A Study of TQB3454 Tablets in Patients With Blood Tumors